Fibrinolytic and antithrombotic therapy: theory, practice, and management
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Oxford
Oxford University Press
2006
|
| Ausgabe: | 2nd ed |
| Schlagworte: | |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | x, 410 p. |
| ISBN: | 9780195155648 0195155645 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044094264 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170217s2006 |||| o||u| ||||||eng d | ||
| 015 | |a GBA616392 |2 dnb | ||
| 020 | |a 9780195155648 |c alk. paper |9 978-0-19-515564-8 | ||
| 020 | |a 0195155645 |c alk. paper |9 0-19-515564-5 | ||
| 035 | |a (ZDB-30-PAD)EBC3053633 | ||
| 035 | |a (ZDB-89-EBL)EBL3053633 | ||
| 035 | |a (OCoLC)71794280 | ||
| 035 | |a (DE-599)BVBBV044094264 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 616.1/3506 |2 22 | |
| 100 | 1 | |a Becker, Richard C. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Fibrinolytic and antithrombotic therapy |b theory, practice, and management |c Richard C. Becker, Frederick A. Spencer |
| 250 | |a 2nd ed | ||
| 264 | 1 | |a Oxford |b Oxford University Press |c 2006 | |
| 300 | |a x, 410 p. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 505 | 0 | |a Historical perspectives in hemostasis, coagulation and fibrinolysis -- Vascular biology, thromboresistance and inflammation -- Atherosclerosis and arterial thrombosis -- Venous thromboembolism -- Cardiac chamber, aortic and valvular thromboembolism -- Fibrinolytic agents -- Aspirin -- Clopidogrel -- Platelet Glycoprotein IIb/IIIa receptor antagonists -- Aggrenox and cilostazol -- Novel platelet antagonists -- | |
| 505 | 0 | |a Combination pharmacotherapy -- Facilitated percutaneous coronary intervention -- Thrombin-directed therapy -- Factor Xa inhibitors -- Direct thrombin inhibitors -- Novel anticoagulants -- Acute coronary syndromes -- Peripheral vascular disease and stroke -- Valvular heart disease and atrial fibrillation -- Plaque-stabilizing therapies -- | |
| 505 | 0 | |a Venous thromboembolism prophylaxis -- Venous thromboembolism treatment -- Fundamentals and patient evaluation -- Platelet antagonists -- Anticoagulants -- Anticoagulation clinics and self-testing -- Platelet antagonists -- Anticoagulants -- Fibrinolytic agents | |
| 650 | 4 | |a Thrombolytic therapy | |
| 650 | 4 | |a Fibrinolytic agents | |
| 650 | 4 | |a Thrombosis |x Treatment | |
| 700 | 1 | |a Spencer, Fredrick A. |e Sonstige |4 oth | |
| 912 | |a ZDB-30-PAD | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029501109 | ||
Datensatz im Suchindex
| _version_ | 1804177151222611969 |
|---|---|
| any_adam_object | |
| author | Becker, Richard C. |
| author_facet | Becker, Richard C. |
| author_role | aut |
| author_sort | Becker, Richard C. |
| author_variant | r c b rc rcb |
| building | Verbundindex |
| bvnumber | BV044094264 |
| collection | ZDB-30-PAD |
| contents | Historical perspectives in hemostasis, coagulation and fibrinolysis -- Vascular biology, thromboresistance and inflammation -- Atherosclerosis and arterial thrombosis -- Venous thromboembolism -- Cardiac chamber, aortic and valvular thromboembolism -- Fibrinolytic agents -- Aspirin -- Clopidogrel -- Platelet Glycoprotein IIb/IIIa receptor antagonists -- Aggrenox and cilostazol -- Novel platelet antagonists -- Combination pharmacotherapy -- Facilitated percutaneous coronary intervention -- Thrombin-directed therapy -- Factor Xa inhibitors -- Direct thrombin inhibitors -- Novel anticoagulants -- Acute coronary syndromes -- Peripheral vascular disease and stroke -- Valvular heart disease and atrial fibrillation -- Plaque-stabilizing therapies -- Venous thromboembolism prophylaxis -- Venous thromboembolism treatment -- Fundamentals and patient evaluation -- Platelet antagonists -- Anticoagulants -- Anticoagulation clinics and self-testing -- Platelet antagonists -- Anticoagulants -- Fibrinolytic agents |
| ctrlnum | (ZDB-30-PAD)EBC3053633 (ZDB-89-EBL)EBL3053633 (OCoLC)71794280 (DE-599)BVBBV044094264 |
| dewey-full | 616.1/3506 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.1/3506 |
| dewey-search | 616.1/3506 |
| dewey-sort | 3616.1 43506 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 2nd ed |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02301nmm a2200421zc 4500</leader><controlfield tag="001">BV044094264</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s2006 |||| o||u| ||||||eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">GBA616392</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780195155648</subfield><subfield code="c">alk. paper</subfield><subfield code="9">978-0-19-515564-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0195155645</subfield><subfield code="c">alk. paper</subfield><subfield code="9">0-19-515564-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC3053633</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL3053633</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)71794280</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044094264</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.1/3506</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Becker, Richard C.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Fibrinolytic and antithrombotic therapy</subfield><subfield code="b">theory, practice, and management</subfield><subfield code="c">Richard C. Becker, Frederick A. Spencer</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2nd ed</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford</subfield><subfield code="b">Oxford University Press</subfield><subfield code="c">2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">x, 410 p.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Historical perspectives in hemostasis, coagulation and fibrinolysis -- Vascular biology, thromboresistance and inflammation -- Atherosclerosis and arterial thrombosis -- Venous thromboembolism -- Cardiac chamber, aortic and valvular thromboembolism -- Fibrinolytic agents -- Aspirin -- Clopidogrel -- Platelet Glycoprotein IIb/IIIa receptor antagonists -- Aggrenox and cilostazol -- Novel platelet antagonists --</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Combination pharmacotherapy -- Facilitated percutaneous coronary intervention -- Thrombin-directed therapy -- Factor Xa inhibitors -- Direct thrombin inhibitors -- Novel anticoagulants -- Acute coronary syndromes -- Peripheral vascular disease and stroke -- Valvular heart disease and atrial fibrillation -- Plaque-stabilizing therapies --</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Venous thromboembolism prophylaxis -- Venous thromboembolism treatment -- Fundamentals and patient evaluation -- Platelet antagonists -- Anticoagulants -- Anticoagulation clinics and self-testing -- Platelet antagonists -- Anticoagulants -- Fibrinolytic agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Thrombolytic therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Fibrinolytic agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Thrombosis</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Spencer, Fredrick A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029501109</subfield></datafield></record></collection> |
| id | DE-604.BV044094264 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:43:30Z |
| institution | BVB |
| isbn | 9780195155648 0195155645 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029501109 |
| oclc_num | 71794280 |
| open_access_boolean | |
| physical | x, 410 p. |
| psigel | ZDB-30-PAD |
| publishDate | 2006 |
| publishDateSearch | 2006 |
| publishDateSort | 2006 |
| publisher | Oxford University Press |
| record_format | marc |
| spelling | Becker, Richard C. Verfasser aut Fibrinolytic and antithrombotic therapy theory, practice, and management Richard C. Becker, Frederick A. Spencer 2nd ed Oxford Oxford University Press 2006 x, 410 p. txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index Historical perspectives in hemostasis, coagulation and fibrinolysis -- Vascular biology, thromboresistance and inflammation -- Atherosclerosis and arterial thrombosis -- Venous thromboembolism -- Cardiac chamber, aortic and valvular thromboembolism -- Fibrinolytic agents -- Aspirin -- Clopidogrel -- Platelet Glycoprotein IIb/IIIa receptor antagonists -- Aggrenox and cilostazol -- Novel platelet antagonists -- Combination pharmacotherapy -- Facilitated percutaneous coronary intervention -- Thrombin-directed therapy -- Factor Xa inhibitors -- Direct thrombin inhibitors -- Novel anticoagulants -- Acute coronary syndromes -- Peripheral vascular disease and stroke -- Valvular heart disease and atrial fibrillation -- Plaque-stabilizing therapies -- Venous thromboembolism prophylaxis -- Venous thromboembolism treatment -- Fundamentals and patient evaluation -- Platelet antagonists -- Anticoagulants -- Anticoagulation clinics and self-testing -- Platelet antagonists -- Anticoagulants -- Fibrinolytic agents Thrombolytic therapy Fibrinolytic agents Thrombosis Treatment Spencer, Fredrick A. Sonstige oth |
| spellingShingle | Becker, Richard C. Fibrinolytic and antithrombotic therapy theory, practice, and management Historical perspectives in hemostasis, coagulation and fibrinolysis -- Vascular biology, thromboresistance and inflammation -- Atherosclerosis and arterial thrombosis -- Venous thromboembolism -- Cardiac chamber, aortic and valvular thromboembolism -- Fibrinolytic agents -- Aspirin -- Clopidogrel -- Platelet Glycoprotein IIb/IIIa receptor antagonists -- Aggrenox and cilostazol -- Novel platelet antagonists -- Combination pharmacotherapy -- Facilitated percutaneous coronary intervention -- Thrombin-directed therapy -- Factor Xa inhibitors -- Direct thrombin inhibitors -- Novel anticoagulants -- Acute coronary syndromes -- Peripheral vascular disease and stroke -- Valvular heart disease and atrial fibrillation -- Plaque-stabilizing therapies -- Venous thromboembolism prophylaxis -- Venous thromboembolism treatment -- Fundamentals and patient evaluation -- Platelet antagonists -- Anticoagulants -- Anticoagulation clinics and self-testing -- Platelet antagonists -- Anticoagulants -- Fibrinolytic agents Thrombolytic therapy Fibrinolytic agents Thrombosis Treatment |
| title | Fibrinolytic and antithrombotic therapy theory, practice, and management |
| title_auth | Fibrinolytic and antithrombotic therapy theory, practice, and management |
| title_exact_search | Fibrinolytic and antithrombotic therapy theory, practice, and management |
| title_full | Fibrinolytic and antithrombotic therapy theory, practice, and management Richard C. Becker, Frederick A. Spencer |
| title_fullStr | Fibrinolytic and antithrombotic therapy theory, practice, and management Richard C. Becker, Frederick A. Spencer |
| title_full_unstemmed | Fibrinolytic and antithrombotic therapy theory, practice, and management Richard C. Becker, Frederick A. Spencer |
| title_short | Fibrinolytic and antithrombotic therapy |
| title_sort | fibrinolytic and antithrombotic therapy theory practice and management |
| title_sub | theory, practice, and management |
| topic | Thrombolytic therapy Fibrinolytic agents Thrombosis Treatment |
| topic_facet | Thrombolytic therapy Fibrinolytic agents Thrombosis Treatment |
| work_keys_str_mv | AT beckerrichardc fibrinolyticandantithrombotictherapytheorypracticeandmanagement AT spencerfredricka fibrinolyticandantithrombotictherapytheorypracticeandmanagement |